Inflammatory and nutritional indices in patients with pheochromocytoma
Abstract
Keywords
References
- Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942. doi:10.1210/jc.2014-1498
- Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011; 40(2):295-vii. doi:10.1016/j.ecl.2011.02.002
- Zhang W, Yu J, Chen Y, et al. Glucose disorders in patients with pheochromocytoma/paraganglioma: profile and influence effects in a large cohort with 705 patients. Endocr Pract. 2025;31(3):269-277. doi:10. 1016/j.eprac.2024.11.004
- Zhang W, Zhou Y, Cui Y, et al. An in-depth exploration of the catecholamine and dyslipidemia relationship in pheochromocytoma and paraganglioma patients: a large Chinese cohort study. Endocrine. 2025;89(2):595-602. doi:10.1007/s12020-025-04277-w
- Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014;16(6):504. doi:10.1186/s13075-014-0504-2
- Bergmann M, Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr. 2002;114(17-18):752-761.
- Zheng K, Liu X, Ji W, Lu J, Cui J, Li W. The efficacy of different inflammatory markers for the prognosis of patients with malignant tumors. J Inflamm Res. 2021;14:5769-5785. doi:10.2147/JIR.S334941
- Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295-3302. doi:10.7150/jca.25691
Details
Primary Language
English
Subjects
Endocrinology
Journal Section
Research Article
Authors
Muzaffer Deniz
0000-0002-8905-3955
Türkiye
Oya Topaloğlu
0000-0003-2501-935X
Türkiye
Reyhan Ersoy
0000-0002-7437-1176
Türkiye
Bekir Çakır
0000-0001-7526-8827
Türkiye
Publication Date
May 22, 2026
Submission Date
March 1, 2026
Acceptance Date
April 9, 2026
Published in Issue
Year 2026 Volume: 8 Number: 3






